Unless otherwise rescheduled by regulation of the Cabinet for Health and Family
Services, the controlled substances listed in this section are included in Schedule III:

Terms Used In Kentucky Statutes 218A.090

  • Anabolic steroid: means any drug or hormonal substance chemically and pharmacologically related to testosterone that promotes muscle growth and includes those substances listed in KRS 218A. See Kentucky Statutes 218A.010
  • Cabinet: means the Cabinet for Health and Family Services. See Kentucky Statutes 218A.010
  • Dosage unit: means a single pill, capsule, ampule, liquid, or other form of administration available as a single unit. See Kentucky Statutes 218A.010
  • Drug: means : (a) Substances recognized as drugs in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them. See Kentucky Statutes 218A.010
  • isomer: means the optical, positional, or geometric isomer. See Kentucky Statutes 218A.010

(1) Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system: Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid; chlorhexadol; glutethimide; lysergic acid; lysergic acid amide; methyprylon; sulfondiethylmethane; sulfonethylmethane; sulfonmethane;
(2) Nalorphine;
(3) Pentazocine (parenteral or injectable form only);
(4) Any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:
(a) Not more than one and four-fifths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;
(b) Not more than one and four-fifths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one (1) or more active nonnarcotic ingredients in recognized therapeutic amounts;
(c) Not more than one and four-fifths (1.8) grams of dihydrocodeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(d) Not more than three hundred (300) milligrams of ethylmorphine, or any of its salts per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with one (1) or more ingredients in recognized therapeutic amounts;
(e) Not more than five hundred (500) milligrams of opium per one hundred (100) milliliters or per one hundred (100) grams, or not more than twenty-five (25) milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(f) Not more than fifty (50) milligrams of morphine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts; and
(g) The Cabinet for Health and Family Services may except by regulation any compound, mixture, or preparation containing any stimulant or depressant substance listed in subsection (1) of this section from the application of all or any part of this chapter if the compound, mixture, or preparation contains one (1) or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the
potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system; and
(5) Any material, compound, mixture, or preparation containing any quantity of any of the following anabolic steroid substances, or any isomer, ester, salt, or derivative thereof:
(a) Boldenone; (b) Clostebol;
(c) Dehydrochlormethyltestosterone; (d) Drostanolone;
(e) Ethylestrenol;
(f) Fluoxymesterone; (g) Formebulone;
(h) Mesterolone;
(i) Methandienone; (j) Methandriol;
(k) Methenolone;
(l) Methyltestosterone; (m) Mibolerone;
(n) Nandrolone;
(o) Norethandrolone; (p) Oxandrolone;
(q) Oxymesterone; (r) Oxymetholone; (s) Stanolone;
(t) Stanozolol; (u) Testolactone;
(v) Testosterone; and
(w) Trenbolone.
This section shall not apply to any material, compound, mixture, or preparation containing any quantity of an anabolic steroid substance, or any isomer, ester, salt, or derivative thereof that is expressly intended for administration through implant to livestock or other nonhuman species, and that is approved by the United States Food and Drug Administration for such use.
Effective: April 27, 2016
History: Amended 2016 Ky. Acts ch. 135, sec. 5, effective April 27, 2016. — Amended
2005 Ky. Acts ch. 99, sec. 534, effective June 20, 2005. — Amended 1998 Ky. Acts ch. 426, sec. 477, effective July 15, 1998. — Amended 1992 Ky. Acts ch. 441, sec. 4, effective July 14, 1992. — Amended 1990 Ky. Acts ch. 160, sec. 1, effective July 13,
1990. — Amended 1980 Ky. Acts ch. 161, sec. 2, effective July 15, 1980. — Amended
1974 Ky. Acts ch. 74, Art. VI, sec. 107(3). — Created 1972 Ky. Acts ch. 226, sec. 10.